Neutropenic fever is a life-threatening condition commonly associated with chemotherapy-induced neutropenia, requiring rapid diagnosis and immediate treatment. Risk stratification tools, such as the MASCC and CISNE scores, help clinicians identify high-risk patients and tailor management strategies. Future efforts should focus on integrating technological advancements, enhancing patient-centered care, and developing novel therapies to reduce recurrence and improve outcomes.
No takes yet. Share an insight, caveat, or question.
Nicholas Pettit (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: